These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32091347)

  • 1. Current Treatment for Cervical Cancer: An Update.
    Sharma S; Deep A; Sharma AK
    Anticancer Agents Med Chem; 2020; 20(15):1768-1779. PubMed ID: 32091347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational drugs for the treatment of cervical cancer.
    Barra F; Lorusso D; Leone Roberti Maggiore U; Ditto A; Bogani G; Raspagliesi F; Ferrero S
    Expert Opin Investig Drugs; 2017 Apr; 26(4):389-402. PubMed ID: 28274154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
    Minion LE; Tewari KS
    Gynecol Oncol; 2018 Mar; 148(3):609-621. PubMed ID: 29666026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of antiproliferative action of a new d-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility.
    Bózsity N; Minorics R; Szabó J; Mernyák E; Schneider G; Wölfling J; Wang HC; Wu CC; Ocsovszki I; Zupkó I
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):247-257. PubMed ID: 27363663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
    Boussios S; Seraj E; Zarkavelis G; Petrakis D; Kollas A; Kafantari A; Assi A; Tatsi K; Pavlidis N; Pentheroudakis G
    Crit Rev Oncol Hematol; 2016 Dec; 108():164-174. PubMed ID: 27931835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
    Liu Y; An Q; Zhao X
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
    Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
    Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic features of cytotoxic activity of flavonoids on human cervical cancer cells.
    Sak K
    Asian Pac J Cancer Prev; 2014; 15(19):8007-19. PubMed ID: 25338977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
    Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
    Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines.
    Souza RP; Bonfim-Mendonça PS; Damke GMZF; de-Assis Carvalho ARB; Ratti BA; Dembogurski DSO; da-Silva VRS; Silva SO; Da-Silva DB; Bruschi ML; Maria-Engler SS; Consolaro MEL
    Anticancer Agents Med Chem; 2018; 18(12):1750-1760. PubMed ID: 29866020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapies in cervical cancer. A systematic review.
    Zagouri F; Sergentanis TN; Chrysikos D; Filipits M; Bartsch R
    Gynecol Oncol; 2012 Aug; 126(2):291-303. PubMed ID: 22504292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways.
    Ding J; Zhang L; Zeng S; Feng T
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1179-1184. PubMed ID: 31103261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and anticervical cancer activity of new benzofuran-pyrazol-hydrazono- thiazolidin-4-one hybrids as potential EGFR inhibitors and apoptosis inducing agents.
    Abbas HS; Abd El-Karim SS
    Bioorg Chem; 2019 Aug; 89():103035. PubMed ID: 31200286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
    Aydinlik S; Dere E; Ulukaya E
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):903-916. PubMed ID: 30825616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.
    Liu J; Cheng Y; He M; Yao S
    Gynecol Endocrinol; 2014 Jun; 30(6):461-5. PubMed ID: 24650367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Aurora A and Aurora B Is Required for the Sensitivity of HPV-Driven Cervical Cancers to Aurora Kinase Inhibitors.
    Martin D; Fallaha S; Proctor M; Stevenson A; Perrin L; McMillan N; Gabrielli B
    Mol Cancer Ther; 2017 Sep; 16(9):1934-1941. PubMed ID: 28522591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
    Li M; Su BS; Chang LH; Gao Q; Chen KL; An P; Huang C; Yang J; Li ZF
    Anticancer Drugs; 2014 Feb; 25(2):161-73. PubMed ID: 24231526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions.
    Kagabu M; Nagasawa T; Sato C; Fukagawa Y; Kawamura H; Tomabechi H; Takemoto S; Shoji T; Baba T
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.